PMID: 7537380Apr 25, 1995Paper

Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library

Proceedings of the National Academy of Sciences of the United States of America
J de KruifT Logtenberg

Abstract

Peripheral blood leukocytes incubated with a semisynthetic phage antibody library and fluorochrome-labeled CD3 and CD20 antibodies were used to isolate human single-chain Fv antibodies specific for subsets of blood leukocytes by flow cytometry. Isolated phage antibodies showed exclusive binding to the subpopulation used for selection or displayed additional binding to a restricted population of other cells in the mixture. At least two phage antibodies appeared to display hitherto-unknown staining patterns of B-lineage cells. This approach provides a subtractive procedure to rapidly obtain human antibodies against known and novel surface antigens in their native configuration, expressed on phenotypically defined subpopulations of cells. This approach does not depend on immunization procedures or the necessity to repeatedly construct phage antibody libraries.

References

Jun 21, 1991·Science·T A Waldmann
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R A WilliamsonD R Burton
Jan 1, 1994·Annual Review of Immunology·G WinterH R Hoogenboom
May 1, 1993·Proteins·T T WuE A Kabat

❮ Previous
Next ❯

Citations

Aug 7, 2007·Cancer Immunology, Immunotherapy : CII·Qing-An YuanGregory P Adams
Oct 1, 1996·Immunology Today·J de KruifT Logtenberg
Jul 5, 2005·Journal of Immunological Methods·Cecilia A W GeuijenJohn de Kruif
May 24, 2005·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·S SiberilJ-L Teillaud
Nov 5, 2002·Clinical Biochemistry·Hassan M E Azzazy, W Edward Highsmith
Apr 3, 2003·International Journal for Parasitology·Liyan ChenJacqueline Sharon
May 24, 2000·Journal of Immunological Methods·M JohnsM A Ritter
Apr 9, 2001·Journal of Immunological Methods·D B PowersJ D Marks
Apr 9, 2001·Journal of Immunological Methods·G CoiaR A Irving
Dec 31, 2002·Journal of Immunological Methods·Katarina RadosevićWillem van Ewijk
Sep 6, 2003·Journal of Immunological Methods·Karin LundinMats A A Persson
May 12, 1997·Journal of Immunological Methods·J L Wung, N R Gascoigne
Feb 3, 1998·Journal of Immunological Methods·T WindB F Clark
Jan 29, 2000·Journal of Immunological Methods·G P Adams, R Schier
Jan 29, 2000·Journal of Immunological Methods·M LittleP Terness
Jan 1, 1997·Molecular Immunology·P S ChowdhuryI Pastan
Apr 6, 1999·Trends in Biotechnology·A Cattaneo, S Biocca
Sep 1, 2000·Advanced Drug Delivery Reviews·F NilssonD Neri
Jun 6, 2000·Advanced Drug Delivery Reviews·H R Hoogenboom de Haard H
Jun 6, 2000·Advanced Drug Delivery Reviews·L Zardi, D Neri
Jan 23, 1998·Human Immunology·M P PistilloG B Ferrara
Oct 17, 2001·Experimental Hematology·B P Mullaney, M G Pallavicini
Jan 25, 2003·Experimental Hematology·Ruiwu LiuKit S Lam
Oct 11, 2003·Biotechnology Advances·I Benhar
Apr 1, 1997·Current Opinion in Immunology·M S HaydenJ A Ledbetter
Oct 12, 2000·Current Opinion in Biotechnology·L J HoltI M Tomlinson
Mar 21, 1998·Current Opinion in Biotechnology·A D Griffiths, A R Duncan
Mar 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R C RooversH R Hoogenboom
Feb 13, 2001·Drug Discovery Today·C Rader
Jul 14, 1998·Immunotechnology : an International Journal of Immunological Engineering·H R HoogenboomR C Roovers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.